Birdwatch Archive

Birdwatch Note Rating

2024-03-23 17:14:54 UTC - NOT_HELPFUL

Rated by Participant: 1C6568C3430CCFA8EE59411DB53E1CC0A76A657EDABFCF988A956EAF0CDDBFD2
Participant Details

Original Note:

The FDA has issued warnings about unapproved formulations of Semaglutide (Better known as Oxempic) for weight loss. Wegovy is the only Semaglutide formulation approved by the FDA for weight loss. This drug may have the same ‘active ingredient’ but it is not the same drug. https://www.cnn.com/2023/05/30/health/fda-compounding-semaglutide/index.html

All Note Details

Original Tweet

All Information

  • noteId - 1768763409279963319
  • participantId -
  • raterParticipantId - 1C6568C3430CCFA8EE59411DB53E1CC0A76A657EDABFCF988A956EAF0CDDBFD2
  • createdAtMillis - 1711214094505
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - NOT_HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 0
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 0
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 0
  • helpfulImportantContext - 0
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 1
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 1
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 1
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 17687634092799633191C6568C3430CCFA8EE59411DB53E1CC0A76A657EDABFCF988A956EAF0CDDBFD2